FDAs National Center for Toxicological Research announces the publication of three International Test Method Standards in Nanotechnology by the Americ...
Federal Register notice: FDA seeks comments on an information collection revision entitled Human Drug Compounding Under Sections 503A and 503B of the ...
Federal Register notice: FDA sends to OMB an information collection extension entitled Guidance on Reagents for Detection of Specific Novel Influenza ...
Sens. Dick Durbin (D-IL), chair of the Senate Judiciary Committee, ranking member Chuck Grassley (R-IA) and Thom Tillis (R-NC) introduce bipartisan le...
CDRH makes available a draft guidance on Power Morcellator containment systems clinical performance assessments.
Some 30 GOP House members call on President Biden to take steps to alleviate a shortage of intravenous contrast agents.
FDA publishes the latest update for its list of off-patent, off-exclusivity drugs for which there are no approved generics.
Federal Register notice: FDA makes available a draft guidance entitled Voluntary Consensus Standards Recognition Program for Regenerative Medicine The...